Editorial comment: Common approaches to dyspnoea management in advanced life-limiting illness

Current Opinion in Supportive and Palliative Care

Volumn 4, Issue 2, 2010, Pages 53-55

  Abernethy, Amy P ^a,b,c   Wheeler, Jane L ^a   Currow, David C ^b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b FLINDERS UNIVERSITY   (Australia)

^c REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DYSPNEA; EDITORIAL; HUMAN; METHODOLOGY; OXYGEN THERAPY; PALLIATIVE THERAPY;

DYSPNEA; HUMANS; OXYGEN INHALATION THERAPY; PALLIATIVE CARE;

EID: 77953864931     PISSN: 17514258     EISSN: 17514266     Source Type: Journal    
DOI: 10.1097/SPC.0b013e328338f921     Document Type: Editorial

References (17)

1. Feinstein AR, Fisher MB, Pigeon JG. Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure. Am J Cardiol 1989; 64:50-55.
2. Hajiro T, Nishimura K, Tsukino M, et al. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD. Chest 1999; 116:1632-1637.
3. Tessier JF, Nejjari C, Letenneur L, et al. Dyspnea and 8-year mortality among elderly men and women: the PAQUID cohort study. Eur J Epidemiol 2001; 17:223-229.
4. Metra M, Teerlink JR, Weatherley BD, et al. Changes in dyspnea during treatment of acute heart failure are correlated with clinical signs, rehospitalizations and mortality: results from the Pre-RELAX-AHF trial. J Card Fail 2009; 15:S62-S63.
5. Abernethy AP, Uronis HE, Wheeler JL, Currow DC. Pharmacological management of breathlessness in advanced disease. Prog Palliat Care 2008; 16:15-20.
6. Abernethy AP, Currow DC, Frith P, Fazekas B. Prescribing palliative oxygen: a clinician survey of expected benefit and patterns of use. Palliat Med 2005;19:168-170.
7. Uronis HE, Currow DC, McCrory DC, et al. Oxygen for relief of dyspnoea in mildly or nonhypoxaemic patients with cancer: a systematic review and metaanalysis. Br J Cancer 2008; 98:294-299.
8. Uronis HE, McCrory DC, Samsa GP, et al. Palliative oxygen for nonhypoxaemic chronic obstructive pulmonary disease. Cochrane Airways Group. Cochrane Database Syst Rev (in press).
9. Uronis HE, Abernethy AP. Oxygen for relief of dyspnea: what is the evidence? Curr Opin Support Palliat Care 2008; 2:89-94.
10. Nonoyama ML, Brooks D, Guyatt GH, Goldstein RS. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am J Respir Crit Care Med 2007;176:343-349.
11. Abernethy AP, McDonald C, Frith P, et al. Palliative oxygen versus medical air for relief of dyspnea: results of an international, multisite, randomized controlled trial. Presented at: 11th Congress of the European Association of Palliative Care; Vienna, Austria; 2009.
12. Currow DC, Fazekas B, Abernethy AP. Oxygen use: patients define symptomatic benefit discerningly. J Pain Symptom Manage 2007; 34:113-114.
13. Cheung WY, Le LW, Zimmermann C. Symptom clusters in patients with advanced cancers. Support Care Cancer 2009; 17:1223-1230.
14. Kim HF, Kunik ME, Molinari VA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000; 41:465-471.
15. Tyler LS. Dyspnea in palliative care patients. In: Lipman AG, Jackson KC, Tyler LS, editors. Evidence-based symptom control in palliative care. Binghamton, New York, USA: The Hawthorn Press, Inc.; 2000.
16. Saunders C. Care of patients suffering from terminal illness at St. Joseph's Hospice, Hackney, London. Nursing Mirror 14 February 1964; pp. vii-x.
17. Abernethy AP, Wheeler JL. Total dyspnoea. Curr Opin Support Palliat Care 2008; 2:110-113.